Clinical Trial Update: Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating a second-line regimen that includes liposomal irinotecan for patients with pancreatic cancer previously treated with irinotecan. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Rui-hua Xu, MD, PhD | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING